January 16, 2019 / 9:32 PM / 8 months ago

BRIEF-Adamis Pharmaceuticals’ Commercial Partner Launches Symjepi (Epinephrine) In The US

Jan 16 (Reuters) - Adamis Pharmaceuticals Corp:

* ADAMIS’ COMMERCIAL PARTNER LAUNCHES SYMJEPI™ (EPINEPHRINE) IN THE US

* ADAMIS PHARMACEUTICALS CORP - WORKING CLOSELY WITH SANDOZ TO PREPARE FOR US LAUNCH OF SYMJEPI 0.15 MG INJECTION

* ADAMIS PHARMACEUTICALS - SYMJEPI WILL BE ROLLED OUT VIA A PHASED LAUNCH AND WILL INITIALLY BE AVAILABLE IN INSTITUTIONAL SETTING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below